Teva holds an approved NDA for its ProAir® HFA Inhalation Aerosol product, which permits Teva to market and sell an inhaler device that administers the API albuterol sulfate. Teva listed several ...
Teva had listed nine patents in the Orange Book for its ProAir® HFA albuterol inhaler. Five of the patents were directed to a dose counter used for the delivery device or the canister used to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback